News
The U.S. Food and Drug Administration extended the review of KalVista Pharmaceuticals' drug for a type of hereditary swelling ...
The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the ...
While it is not the most common allergy in the country, almost 2 million Americans have an allergy to soy, according to Food ...
WEDNESDAY, June 11, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) says it plans to use artificial ...
The U.S. Food and Drug Administration on Thursday expanded the use of Moderna's respiratory syncytial virus vaccine to a ...
By Lori Solomon HealthDay ReporterWEDNESDAY, June 11, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...
To obtain full approval of the drug for treatment of chemotherapy-induced diarrhea (CID) and to expand the indication of ...
Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS ...
3d
Medpage Today on MSNFDA Officials Lay Out Vision for AgencyThe new FDA commissioner and Center for Biologics Evaluation and Research (CBER) director laid out their vision for the ...
The federal government plans to develop a new definition of ultraprocessed foods, a wide-ranging group of snacks, meals and ...
18h
Futurism on MSNThe FDA Is Already Outsourcing Drug and Food Analysis to Error-Plagued AI ChatbotThe FDA plans to "unleash AI" on new drug evaluations in order to "radically increase efficiency in the review process." ...
The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include individuals 18-59 years of age who are at increased risk for severe illness from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results